Background: Infantile spasm is a type of pediatric seizure often associated with a negative prognosis. The aim of this study was to evaluate the role of Magnetic Resonance Imaging (MRI) in categorization and neurodevelopmental outcomes in children with infantile spasm. Materials and Methods: A retrospective study of the clinical charts and MRI findings of infants diagnosed with infantile spasm between December 2007 and February 2014. Results: A total of 26 children (16 males; 1.6/1) were included: 8 of unknown etiology and 18 with a genetic/structural-metabolic causes. Unknown etiology cases revealed normal brain MRI in 5/8 (62.5%). In the genetic/ structural-metabolic group, only 2/18 (11.1%) had normal imaging. Abnormal imaging findings significantly correlated with genetic/structural-metabolic infantile spasm which had unfavorable neurodevelopmental outcome. Conclusion: Neuroimaging conveys substantial information to the further categorization of children with infantile spasm, providing not only relevant information of the underlying cause but also the prediction of the neurodevelopmental outcome.
and iii) hypsarrhythmia pattern on electroencephalography (EEG) [9] . The great majority of patients with infantile spasms will also have developmental problems and hypsarrhythmia on EEG, and therefore patients with West syndrome or just infantile spasms tend to be reported as one group [10] [11] . This is the group in our study.
The prognosis of infantile spasm is multifactorial and depends on: i) the underlying cause, i.e. congenital brain malformation; ii) the pattern of electroencephalography; iii) the appearance of seizures prior to the spasms; and iv) a rapid response to treatment [12] .
Current classification of infantile spasm refers to genetic, structural-metabolic, and unknown cause [13] , replacing the previous use of idiopathic, symptomatic, and cryptogenic respectively. Etiologic classification of infantile spasm has shown structuralmetabolic abnormalities in 68% of children, unknown etiology in 24% of children and genetic causes in 8% of children [14] . MRI can provide information regarding etiology, thus can aid in the categorization of infantile spasm [15] .
The purpose of this study was to compare MRI findings with neurodevelopmental outcomes in children with infantile spasm where preliminary clinical work up did not lead to a specific etiological diagnosis. Prior to evaluation of the MRI findings, the cases were classified as structural-metabolic, genetic, or infantile spasm of unknown etiology based on clinical information, EEG and laboratory tests.
Materials and Methods

Subjects
MRI Technique and Interpretation
All children underwent an MRI scan on a 1.5 Tesla clinical MR system (Signa HD, General Electric Healthcare Technologies, Waukesha, WI, USA). All children were given anesthesia which was administered by a pediatric anesthesiologist as per departmental protocol. Images were acquired using an 8-channel head coil. All of the MRI's in- 
Data Collection
Medical records were systematically reviewed. Data regarding gestational age at birth, the age at first spasm, course of the disease, treatment history, time under follow-up and the outcome of the patient was reviewed. MR images were reviewed by a pediatric radiology fellow (AK) who was blinded to the underlying diseases, clinical history and outcome. Image findings were compared to the clinical report in the Picture Archiving and Communication System PACS. The median follow-up period for infantile spasm patients was 29 months (range 1 -66.7 months).
The diagnosis of infantile spasm and the EEG findings were confirmed by a pediatric neurologist with 7 years of experience in pediatric neurology (ES).
All patients received therapeutic regimen including Vigabatrin and/or adrenocorticotrophic hormone ACTH.
The initial classification of infantile spasm was correlated to the MRI findings and final diagnosis, as documented in clinical follow-up records, to evaluate the usefulness of MRI in the categorization of infantile spasm. Finally, the neurodevelopmental outcome was evaluated according to response to treatment for spasms and seizure control and the presence of any degree of developmental delay/regression for each group.
Children with no or mild developmental delay, without spasm or other seizure activities were categorized as favorable neurodevelopmental outcome while children with moderate-severe developmental delay and with other seizure activities and/or spasm were categorized as unfavourable neurodevelopmental outcome. The degree of developmental delay (mild, moderate, severe) was extracted from the chart information as per clinicians' decision. Data was analyzed using a two tailed Fisher exact test for any correlations and the p-values were calculated.
Results
The age of initial infantile spasm onset ranged between 2 -11.5 months (mean 6.4 months). The mean onset age was 6.6 months (5 -9 months) for infantile spasm of unknown etiology, and 6 months (2 -11.5 months) for genetic/structural-metabolic infantile spasm. Clinical follow-up time ranged between 1 -66.7 months (mean 29 months).
Demographics are summarized in Table 1 . . T2 weighted images demonstrate lissencephaly agyria/pachygyria and thickened, band-like heterotopia in subcortical white matter known as double-cortex (arrows). The thickness of the band heterotopia is marked with a brace in the image (c). The image findings assisted in coming to a final diagnosis for this child.
Value of Neuroimaging for the Clinical Diagnosis
Imaging Findings of Infantile Spasm
The etiologic causes in the structural-metabolic or genetic group are summarized in † IS = infantile spam; HIE = hypoxic-ischemic encephalopathy; T = thalamus; P/C = putamen/caudate; GP = globus pallidus; PV = periventricular white matter; W = white matter; P/MB = pons/midbrain; CP = cerebral peduncles; CC = corpus callosum; WV = widened ventricle; WCSF = widening of CSF space; CD = cortical dysplasia; PG-PMG/pmg = pachygyria-polymicrogyria; HT = heterotopia; T = tuber; AS/S = absent septum pellucidum/schizencephaly; M = megalencephaly; L = lissencephaly; dis = disease. † † 2 cases with trisomies 21 and 15 had normal imaging. They are not included in the table. † † † Case with trisomy 15 revealed rvisc "reversible vigabatrin-induced signal changes" and not shown in this table.
Among infantile spasm of unknown etiology, complete resolution of spasm was achieved in 7/8 (87.5%) cases; but 3 of them continued to have other seizure types (one refractory, one focal motor and one complex partial seizure). This group of infantile spasm encountered a spectrum of delay in developmental milestone achievements in 7/8 (87.5%) cases; 3 with mild delay. Only 1/8 (12.5%) case with infantile spasm of unknown etiology achieved a normal developmental milestone at 26.6 months follow-up with complete resolution of spasm and no seizure activities on anticonvulsant (Table   5 ).
In contrary, among the structural-metabolic and genetic infantile spasm cases, there was heterogeneity in resolution of spasm and other seizure activities. As shown in Table 5 and Table 6 , spasm resolution irrespective of having other types of seizures, was observed in 10/18 (55.55%) children while seizures with/without spasm continued in 12/18 (66.67%) children; 4 of whom had refractory seizures. Only 2/18 (11.1%) children categorized as structural-metabolic and genetic infantile spasm became spasm and seizure free in follow-up.
The difference of spasm resolution between the infantile spasm of unknown etiology and structural-metabolic/genetic group was not statistically significant (p-value = 0.19).
All children with structural-metabolic and genetic infantile spasm demonstrated developmental delay including regression in 2 patients (Table 6 ).
Among the group of infantile spasm with unknown etiology, 5/8 (62.5%) cases had favorable neurodevelopmental outcome regarding spasm resolution, discontinued seizure activity and mild or no developmental delay while only 1/18 children in the structural-metabolic or genetic cases had favorable outcome (Diagrams 2 (a)-(c) ). The difference was significant (p-value = 0.004). Table 5 . Outcome of infantile spasm of unknown etiology. If patient had spasm, seizure, developmental delay or favorable neurodevelopmental outcome, it is marked as *. HIE = hypoxic-ischemic encephalopathy; dys = dysplasia; con = congenital; N = not applicable (Patient deceased). Reg = regression; R = refractory; syn = syndrome. † = this patient had mild delay.
Treatment Related Imaging Abnormality
Vigabatrin-induced signal changes on MRI were seen in 2/26 cases (7.7%); both with signal abnormalities in the globus pallidi that disappeared after discontinuation of Vigabatrin ( Figure 3 ).
Discussion
We targeted brain MRI and its role in the etiologic work-up and prognosis of infantile spasm of unknown etiology. Neuroimaging in our study group had substantial influence to further classify infantile spasm in patients when the preliminary clinical evaluation and work-up did not reach a specific diagnosis (16/26 (61.54%) in our cohort (p-value = 0.0256)).
In our study, MRI identified brain abnormalities in 73.1% (19/26) of cases versus 26.9% (7/26) of cases with normal imaging. This is comparable to Saltik et al. [16] who The underlying cause of brain abnormalities in our structural-metabolic or genetic group was similar to a larger series by Wheless et al. [21] including: cerebral dysgenesis in 25.4% of cases, tuberous sclerosis complex (TSC) in 13.7% of cases, hypoxic-ischemic encephalopathy (HIE) in 8.8% of cases and chromosomal anomaly in 8.8% of cases.
Our data indicated that normal imaging was rare in structural-metabolic/genetic infantile spasm and if present, did not carry any predictive value regarding better outcomes compared to structural-metabolic/genetic infantile spasm with abnormal MRI. Being aware of the underlying etiology is possibly the most important criterion to predict the outcome of children with infantile spasm. As established in previous studies [22] [23], infantile spasm of unknown etiology revealed normal MRI or non-specific changes and carried favorable outcomes when compared to structural-metabolic/genetic infantile spasm in our study.
The limitations of this study include the small sample size, heterogeneity of the cases, and the length of time that the cases were followed. It also suffers from lack of specific developmental testing because it is a retrospective study and as a result the neurodevelopmental outcome is evaluated on the data in the patient's clinical chart.
Conclusion
In summary, i) MRI has a well-established role in identifying the cause of infantile spasm, adding information in 1/3 cases with previously unknown etiology; ii) non-specific findings on MRI follow the same outcome as normal MRI in our cohort; and iii) resolution of spasm is independent of MRI findings, therefore MRI cannot predict spasm medication response.
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